Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 146

1.

Methodologic considerations for studies of chronic nausea and vomiting in adults and children.

Hasler WL, Li BU, Koch KL, Parkman HP, Kovacic K, McCallum RW.

Auton Neurosci. 2016 Aug 3. pii: S1566-0702(16)30122-9. doi: 10.1016/j.autneu.2016.08.001. [Epub ahead of print] Review.

PMID:
27539628
2.

Nausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesis.

Parkman HP, Hallinan EK, Hasler WL, Farrugia G, Koch KL, Calles J, Snape WJ, Abell TL, Sarosiek I, McCallum RW, Nguyen L, Pasricha PJ, Clarke J, Miriel L, Lee L, Tonascia J, Hamilton F; NIDDK Gastroparesis Clinical Research Consortium (GpCRC).

Neurogastroenterol Motil. 2016 Jun 27. doi: 10.1111/nmo.12893. [Epub ahead of print]

PMID:
27350152
3.

Endoscopic Gastric Food Retention in Relation to Scintigraphic Gastric Emptying Delays and Clinical Factors.

Coleski R, Baker JR, Hasler WL.

Dig Dis Sci. 2016 Sep;61(9):2593-601. doi: 10.1007/s10620-016-4173-7. Epub 2016 May 19.

PMID:
27193562
4.

Gastroduodenal Disorders.

Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ.

Gastroenterology. 2016 May;150(6):1380-92. doi: 10.1053/j.gastro.2016.02.011.

PMID:
27147122
5.

Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.

Drossman DA, Hasler WL.

Gastroenterology. 2016 May;150(6):1257-61. doi: 10.1053/j.gastro.2016.03.035. No abstract available.

PMID:
27147121
6.

Rome IV - Gastroduodenal Disorders.

Stanghellini V, Talley NJ, Chan F, Hasler WL, Malagelada J, Suzuki H, Tack J.

Gastroenterology. 2016 Feb 15. pii: S0016-5085(16)00177-3. doi: 10.1053/j.gastro.2016.02.011. [Epub ahead of print]

PMID:
27144626
7.

Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes.

Koch KL, Hasler WL, Yates KP, Parkman HP, Pasricha PJ, Calles-Escandon J, Snape WJ, Abell TL, McCallum RW, Nguyen LA, Sarosiek I, Farrugia G, Tonascia J, Lee L, Miriel L, Hamilton F; NIDDK Gastroparesis Clinical Research Consortium (GpCRC).

Neurogastroenterol Motil. 2016 Jul;28(7):1001-15. doi: 10.1111/nmo.12800. Epub 2016 Mar 6.

PMID:
26946489
8.

Blunting of Colon Contractions in Diabetics with Gastroparesis Quantified by Wireless Motility Capsule Methods.

Coleski R, Wilding GE, Semler JR, Hasler WL.

PLoS One. 2015 Oct 28;10(10):e0141183. doi: 10.1371/journal.pone.0141183. eCollection 2015.

9.

Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis.

Pasricha PJ, Yates KP, Nguyen L, Clarke J, Abell TL, Farrugia G, Hasler WL, Koch KL, Snape WJ, McCallum RW, Sarosiek I, Tonascia J, Miriel LA, Lee L, Hamilton F, Parkman HP.

Gastroenterology. 2015 Dec;149(7):1762-1774.e4. doi: 10.1053/j.gastro.2015.08.008. Epub 2015 Aug 21.

PMID:
26299414
10.

Regional gastrointestinal transit and pH studied in 215 healthy volunteers using the wireless motility capsule: influence of age, gender, study country and testing protocol.

Wang YT, Mohammed SD, Farmer AD, Wang D, Zarate N, Hobson AR, Hellström PM, Semler JR, Kuo B, Rao SS, Hasler WL, Camilleri M, Scott SM.

Aliment Pharmacol Ther. 2015 Sep;42(6):761-72. doi: 10.1111/apt.13329. Epub 2015 Jul 29.

PMID:
26223837
11.

Amitriptyline for Functional Dyspepsia: Importance of Symptom Profile and Making a Case for Gastric Emptying Testing.

Hasler WL, Koch KL.

Gastroenterology. 2015 Aug;149(2):270-2. doi: 10.1053/j.gastro.2015.06.017. Epub 2015 Jun 25. No abstract available.

PMID:
26116797
12.

Symptomatic management for gastroparesis: antiemetics, analgesics, and symptom modulators.

Hasler WL.

Gastroenterol Clin North Am. 2015 Mar;44(1):113-26. doi: 10.1016/j.gtc.2014.11.009. Epub 2014 Dec 26. Review.

PMID:
25667027
13.

Association of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis.

Bernard CE, Gibbons SJ, Mann IS, Froschauer L, Parkman HP, Harbison S, Abell TL, Snape WJ, Hasler WL, McCallum RW, Sarosiek I, Nguyen LA, Koch KL, Tonascia J, Hamilton FA, Kendrick ML, Shen KR, Pasricha PJ, Farrugia G; NIDDK Gastroparesis Clinical Research Consortium (GpCRC).

Neurogastroenterol Motil. 2014 Sep;26(9):1275-84. doi: 10.1111/nmo.12389. Epub 2014 Jul 13.

14.

The use of SmartPill for gastric monitoring.

Hasler WL.

Expert Rev Gastroenterol Hepatol. 2014 Aug;8(6):587-600. doi: 10.1586/17474124.2014.922869. Epub 2014 May 31. Review.

PMID:
24881810
15.

Emerging drugs for the treatment of gastroparesis.

Hasler WL.

Expert Opin Emerg Drugs. 2014 Jun;19(2):261-79. doi: 10.1517/14728214.2014.899353. Epub 2014 Mar 26. Review.

PMID:
24669936
16.

Challenges of managing pain in constipation-predominant IBS: clinical perspectives on antinociceptive actions of linaclotide.

Hasler WL, Owyang C.

Gastroenterology. 2013 Dec;145(6):1196-9. No abstract available.

PMID:
24409483
17.

Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial.

Parkman HP, Van Natta ML, Abell TL, McCallum RW, Sarosiek I, Nguyen L, Snape WJ, Koch KL, Hasler WL, Farrugia G, Lee L, Unalp-Arida A, Tonascia J, Hamilton F, Pasricha PJ.

JAMA. 2013 Dec 25;310(24):2640-9. doi: 10.1001/jama.2013.282833.

18.

Pathology of emesis: its autonomic basis.

Hasler WL.

Handb Clin Neurol. 2013;117:337-52. doi: 10.1016/B978-0-444-53491-0.00027-4.

PMID:
24095137
19.

Geography lessons: scrutinizing state-by-state differences in inpatient gastroparesis care.

Hasler WL.

Dig Dis Sci. 2013 Oct;58(10):2743-5. doi: 10.1007/s10620-013-2815-6. No abstract available.

PMID:
23934413
20.

Cholecystectomy and clinical presentations of gastroparesis.

Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, Farrugia G, Koch KL, Calles J, Abell TL, Sarosiek I, McCallum RW, Lee L, Unalp-Arida A, Tonascia J, Hamilton F.

Dig Dis Sci. 2013 Apr;58(4):1062-73. doi: 10.1007/s10620-013-2596-y. Epub 2013 Mar 2.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk